ArticleCognitive, affective & behavioral neuroscience2025
Reward magnitude-specific delay discounting differentiates mania versus depression risk.
Article in Cognitive, affective & behavioral neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy of Different Combination Therapies for Mania in Bipolar Disorder: A Systematic Review and Meta-Analysis.Brain and behavior · 2025Pooled it
- No Evidence of Moderated Impulsivity Following Administration of the IMPase Inhibitor Ebselen in Healthy Adults.Human psychopharmacology · 2026Trial
- Neural Markers of Reward Valuation and Impulsive Decision-Making in Mania Risk.JAMA psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Mania/hypomania, the pathognomonic feature of bipolar disorder (BD), is characterized by elevated impulsivity, often assessed via delay discounting-the preference for smaller, immediate versus larger, delayed rewards. It remains unclear whether delay discounting differentiates BD from non-BD individuals or serves as an objective behavioral marker of mania/hypomania versus depression risk. Bipolar disorder (n = 40) and non-BD (n = 187) individuals were recruited, with the latter encompassing a range of mania/hypomania and depression risk and stratified into mania/hypomania and depression risk tertiles. Kruskal-Wallis and Dunn's tests evaluated delay discounting rates (k values), assessed via the 27-Item Monetary Choice Questionnaire, across both risk groups compared to the BD group. Significant group effects were found for overall and geomean k values in both mania/hypomania (overall k: χ
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.